Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 34.28M P/E - EPS this Y 59.30% Ern Qtrly Grth -
Income -124.65M Forward P/E -0.92 EPS next Y 39.90% 50D Avg Chg 15.00%
Sales 60.26M PEG - EPS past 5Y - 200D Avg Chg -37.00%
Dividend N/A Price/Book 0.44 EPS next 5Y - 52W High Chg -88.00%
Recommedations 2.70 Quick Ratio 3.81 Shares Outstanding 6.03M 52W Low Chg 55.00%
Insider Own 16.89% ROA -28.31% Shares Float 4.13M Beta 0.57
Inst Own 52.18% ROE -118.52% Shares Shorted/Prior 13.83K/30.61K Price 0.29
Gross Margin 36.71% Profit Margin -206.85% Avg. Volume 443,666 Target Price 13.83
Oper. Margin -60.40% Earnings Date May 13 Volume 463,264 Change 6.76%
About Science 37 Holdings, Inc.

Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data. The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina. As of March 11, 2024, Science 37 Holdings, Inc. operates as a subsidiary of eMed, LLC.

Science 37 Holdings, Inc. News
03/12/24 eMed completes tender offer for all outstanding shares of Science 37
02/12/24 eMed commences tender offer for Science 37
01/29/24 Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment
12/12/23 Science 37 Receives Top Honors in Everest PEAK Matrix®
12/07/23 Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
12/05/23 Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023
11/12/23 Science 37 Holdings, Inc. (NASDAQ:SNCE) Q3 2023 Earnings Call Transcript
11/11/23 It's Down 28% But Science 37 Holdings, Inc. (NASDAQ:SNCE) Could Be Riskier Than It Looks
11/07/23 Science 37 Holdings Inc (SNCE) Reports Q3 2023 Financial Results
11/07/23 Science 37 Reports Third Quarter 2023 Financial Results
10/24/23 Science 37 to Report Third Quarter 2023 Financial Results on November 7, 2023
09/20/23 Science 37 Chief Delivery Officer, Darcy Forman, Named to Prestigious PharmaVoice 100 List
09/13/23 Science 37 Recognized in the Gartner® Hype Cycle™ for Life Science Clinical Development, 2023
09/12/23 Science 37 Named Market Leader for Global Decentralized Clinical Trials by Frost & Sullivan
09/05/23 Science 37 to Participate in H.C. Wainwright 25th Annual Global Investment Conference
08/15/23 Science 37 Recognized as Best Digital Health Solution Nominee at 2023 Prix Galien USA Awards
08/11/23 Increasing losses over year doesn't faze Science 37 Holdings (NASDAQ:SNCE) investors as stock rallies 122% this past week
08/08/23 Science 37 Reports Second Quarter 2023 Financial Results
07/25/23 Science 37 to Report Second Quarter 2023 Financial Results on August 8, 2023
07/11/23 Synlogic Partners with Science 37 on Pivotal Study for Investigational Drug for Phenylketonuria (PKU)
SNCE Chatroom

User Image Stock_Titan Posted - 4 days ago

$SNCE Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial https://www.stocktitan.net/news/SNCE/science-37-delivers-22x-faster-enrollment-than-traditional-methods-6cmj8w5t32jv.html

User Image Stock_Titan Posted - 04/17/24

$SNCE Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment https://www.stocktitan.net/news/SNCE/science-37-provides-fully-consented-patients-to-sites-to-supplement-f2z3zmj9a5qi.html

User Image parabolicrunners Posted - 03/12/24

$SNCE

User Image Stock_Titan Posted - 03/12/24

$SNCE eMed completes tender offer for all outstanding shares of Science 37 https://www.stocktitan.net/news/SNCE/e-med-completes-tender-offer-for-all-outstanding-shares-of-science-4zggs1e8snag.html

User Image SM095 Posted - 03/12/24

Pending news list: $LMFA, $CUROQ,$SNCE, $SOVO

User Image Mergerbrief Posted - 03/11/24

$SNCE eMed, LLC - Tender Offer(Midnight) expires mergerbrief.com

User Image DonCorleone77 Posted - 02/12/24

$SNCE Tender offer for Science 37 by eMed commences eMed's wholly-owned subsidiary Marlin Merger Sub has commenced a cash tender offer to purchase all the outstanding shares of common stock, par value $0.0001 per share, of Science 37 for a price of $5.75 per share. A successful consummation of the tender offer will be followed by a merger to acquire any untendered shares of Science 37 for the same price payable in the tender offer. The offer will expire at 12:00 midnight, NYC time, at the end of the day of March 11, unless extended. The offer is subject to customary closing conditions, including the tender of at least a majority in voting power of the shares of Science 37 common stock then issued and outstanding and is not subject to a financing condition.

User Image parabolicrunners Posted - 02/12/24

$SNCE

User Image Stock_Titan Posted - 02/12/24

$SNCE eMed commences tender offer for Science 37 https://www.stocktitan.net/news/SNCE/e-med-commences-tender-offer-for-science-6a3nye41gipb.html

User Image TickerDD_com Posted - 02/07/24

From 2/2/2024, looking back across 22 Month-Ends for SNCE, Percentage Change of Average Monthly Price had Equal (50%) while Percentage Change of Average Monthly Volume had All Positives (100%) $SNCE #SNCE #SNCEStock #TickerDD #SNCEPrice https://www.youtube.com/watch?v=0uQVTCXvO1E

User Image kelly1874 Posted - 3 months ago

$IFBD that was a sweet move; so clean & quick with no fuss. Reminds me of what happened to $SNCE on March 17. Similar sudden spike just before closing. Congrats to all of you who banked on this one; wish I could have joined you but had already shut it down!

User Image FooTie402 Posted - 01/31/24

$SNCE What a shit deal long term share holders got here

User Image StocksPatents Posted - 01/30/24

$SNCE https://halpersadeh.com/actions/science-37-holdings-inc

User Image ikkydiphoenix Posted - 01/29/24

$SNCE the deal is so bad that i'm surprised they refused my 0.0000001$ offer..

User Image swingingtech Posted - 01/29/24

$QQQ $SNCE $SOFI $CDLX https://wallstreetwaves.com/crude-oil-down-over-1-science-37-holdings-shares-spike-higher/

User Image tradingtwenty Posted - 01/29/24

$SNCE has trended 7 times in the past 24 hours (based on 5 minute intervals). Latest article on Jan 29, 2024 07:30 AM: Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment Link: https://tradingtwenty.com/news/336929/science-37-to-be-acquired-by-emed-expanding-access-to-patients-and-accelerating-enrollment

User Image hidjay01 Posted - 01/29/24

$SNCE buy more ! target 30 !

User Image hidjay01 Posted - 01/29/24

User Image MasterOfMyDomains Posted - 01/29/24

$SNCE stupid

User Image AKnewMann Posted - 01/29/24

$SNCE I take it this deal will have to be approved by shareholders

User Image AKnewMann Posted - 01/29/24

$SNCE $5.75 pps acquisition is robbery

User Image PatJo Posted - 01/29/24

$SNCE https://www.marketwatch.com/amp/story/science-37-holdings-to-be-acquired-for-38-million-aab4a3b2

User Image DonCorleone77 Posted - 01/29/24

$SNCE Science 37 reaffirms 2023 revenue view $58M-$59M, consensus $58.37M In addition to the transaction announcement, Science 37 is providing a business update. Gross bookings were $22.3 million and $102.0 million for the quarter ended and full year ended December 31, 2023. Net of cancellations and negative scope changes, bookings were ($15.7) million and $18.7 million for the quarter ended and full year ended December 31, 2023. $32.2 million of fourth quarter realization adjustments were the result of three large studies that were canceled due to efficacy or customer portfolio prioritization. Revenue for the full year ended December 31, 2023 is expected to be within the most recently issued guidance of $58 to $59 million. Adjusted EBITDA for the full year ended December 31, 2023 is expected to be better than the most recently issued guidance of ($32.5) million. Cash as of December 31, 2023 was in excess of $50.0 million, which is consistent with the most recently issued guidance..

User Image DonCorleone77 Posted - 01/29/24

$SNCE Science 37 to be acquired by eMed for $5.75 per share in cash Science 37 Holdings has entered into a definitive merger agreement to be acquired by eMed, the leader in on-demand virtual care and treatment for consumers. With the most authoritative in-home testing and treatment solution available across a variety of indications, the largest real-time network of certified remote proctors, and Test-to-Treat technology that streamlines the patient enrollment process, eMed brings significant resources to enhance Science 37's ability to access unique patients, enroll studies faster, and ensure long-term sustainability. The transaction, which has been unanimously approved by Science 37 Board of Directors, is valued at an equity value of approximately $38 million and will be structured as an all-cash tender offer to acquire all outstanding shares of Science 37. Under the terms of the agreement, eMed, through its wholly owned subsidiary....

User Image TA_Kongen Posted - 01/29/24

$SNCE LOL 5.75 per share. Disaster for longs.

User Image HaltTradeAlert Posted - 01/29/24

$SNCE Halt Time: 07:25:00 Issue Symbol: SNCE Reason Code: T1 Stock Price: $4.7400 Market Cap: 28.297M Volume: 29,193 Relative Volume: 0.88 Shares Float: 3.96M Get this alert real time and sent to your phone just like a text by going to our website and joining our community for FREE! We just launched this service! Help us spread the word ! www.HaltTradeAlert.com

User Image hidjay01 Posted - 01/26/24

User Image hidjay01 Posted - 01/26/24

$SNCE Buy more !

User Image DipBuyInvester Posted - 01/24/24

$SNCE CYN Set for run!!

User Image Pedrobuffet Posted - 01/19/24

$SNCE nice move … healthcare undervalued stocks will move fast in the coming weeks i think

Analyst Ratings
Baird Neutral Jan 30, 24
Craig-Hallum Hold Jan 29, 24